X4 Pharmaceuticals(XFOR) - 2023 Q2 - Quarterly Report
X4 Pharmaceuticals(XFOR)2023-08-10 20:33UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________________________________________________ FORM 10-Q _____________________________________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 27-3181608 (I.R.S. Employer Identification No.) 02134 (Zip Code) For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 O ...